Variant report

Variant	nsv8772
Chromosome Location	chr11:3602703-3605972
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:74)
CpG islands
(count:122)
Chromatin interactive
region (count:0)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:74 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CBX3	chr11:3602459-3602769	K562	blood:	n/a	n/a
2	CEBPB	chr11:3605601-3605791	IMR90	lung:	n/a	n/a
3	CTCF	chr11:3602382-3602718	GM10266	blood:	n/a	n/a
4	CTCF	chr11:3602254-3602804	A549	lung:	n/a	n/a
5	CTCF	chr11:3602560-3602710	Hela-S3	cervix:	n/a	n/a
6	CTCF	chr11:3602740-3602890	HRPEpiC	eye:	n/a	n/a
7	CTCF	chr11:3602350-3602742	H1-hESC	embryonic stem cell:	n/a	n/a
8	CTCF	chr11:3602560-3602710	AG04450	lung:	n/a	n/a
9	CTCF	chr11:3602394-3602760	LNCaP	prostate:	n/a	n/a
10	CTCF	chr11:3602740-3602890	NHEK	skin:	n/a	n/a
11	CTCF	chr11:3602362-3602709	A549	lung:	n/a	n/a
12	CTCF	chr11:3602379-3602725	Spleen_OC	spleen:	n/a	n/a
13	CTCF	chr11:3602560-3602710	HVMF	connective:	n/a	n/a
14	CTCF	chr11:3602384-3602705	Pancreas_OC	pancreas:	n/a	n/a
15	CTCF	chr11:3602560-3602710	GM06990	blood:	n/a	n/a
16	CTCF	chr11:3602355-3602753	K562	blood:	n/a	n/a
17	CTCF	chr11:3602833-3602878	GM10248	blood:	n/a	n/a
18	CTCF	chr11:3602416-3602704	H1-hESC	embryonic stem cell:	n/a	n/a
19	CTCF	chr11:3602412-3602705	GM12891	blood:	n/a	n/a
20	CTCF	chr11:3602383-3602727	A549	lung:	n/a	n/a
21	CTCF	chr11:3602201-3602846	K562	blood:	n/a	n/a
22	CTCF	chr11:3602307-3602752	K562	blood:	n/a	n/a
23	CTCF	chr11:3602415-3602703	GM19239	blood:	n/a	n/a
24	CTCF	chr11:3602221-3602933	A549	lung:	n/a	n/a
25	CTCF	chr11:3602560-3602710	HepG2	liver:	n/a	n/a
26	CTCF	chr11:3602740-3602890	GM12870	blood:	n/a	n/a
27	CTCF	chr11:3602560-3602710	HMF	breast:	n/a	n/a
28	CTCF	chr11:3602560-3602710	HCT-116	colon:	n/a	n/a
29	CTCF	chr11:3602740-3602890	HCPEpiC	choroid plexus:	n/a	n/a
30	CTCF	chr11:3602397-3602716	GM13977	blood:	n/a	n/a
31	CTCF	chr11:3602560-3602710	K562	blood:	n/a	n/a
32	CTCF	chr11:3602382-3602713	IMR90	lung:	n/a	n/a
33	CTCF	chr11:3602760-3602910	GM12864	blood:	n/a	n/a
34	CTCF	chr11:3602377-3602714	GM12878	blood:	n/a	n/a
35	CTCF	chr11:3602560-3602710	GM12874	blood:	n/a	n/a
36	CTCF	chr11:3602560-3602710	AG04449	skin:	n/a	n/a
37	CTCF	chr11:3602900-3603050	NHLF	lung:	n/a	n/a
38	CTCF	chr11:3602387-3602716	Medullo	brain:	n/a	n/a
39	CTCF	chr11:3601916-3602762	SK-N-SH	brain:	n/a	n/a
40	CTCF	chr11:3602413-3602712	Kidney_OC	kidney:	n/a	n/a
41	CTCF	chr11:3602780-3602930	HAc	cerebellar:	n/a	n/a
42	CTCF	chr11:3602780-3602930	HVMF	connective:	n/a	n/a
43	ELF1	chr11:3602355-3602752	GM12878	blood:	n/a	n/a
44	FOSL2	chr11:3602250-3602718	HepG2	liver:	n/a	n/a
45	GABPA	chr11:3602390-3602739	H1-hESC	embryonic stem cell:	n/a	n/a
46	IRF4	chr11:3602344-3602761	GM12878	blood:	n/a	n/a
47	JUND	chr11:3602325-3602755	A549	lung:	n/a	n/a
48	MAX	chr11:3602477-3602706	K562	blood:	n/a	n/a
49	PAX5	chr11:3602846-3603082	GM12878	blood:	n/a	n/a
50	PAX5	chr11:3602375-3602719	GM12878	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:3602845-3602895	H1-hESC	embryonic stem cell:	embryo
2	chr11:3605970-3606020	HIPEpiC	eye:	n/a
3	chr11:3602845-3602895	HCT-116	colon:	n/a
4	chr11:3605970-3606020	NB4	blood:	n/a
5	chr11:3605970-3606020	HCF	heart:	n/a
6	chr11:3602845-3602895	HCPEpiC	choroid plexus:	n/a
7	chr11:3602845-3602895	Caco-2	colon:	n/a
8	chr11:3602845-3602895	AG10803	skin:	n/a
9	chr11:3602845-3602895	NT2-D1	testis:	n/a
10	chr11:3602845-3602895	PFSK-1	brain:	n/a
11	chr11:3602845-3602895	RPTEC	kidney:	n/a
12	chr11:3605970-3606020	HMEC	breast:	n/a
13	chr11:3602845-3602895	K562	blood:	n/a
14	chr11:3605970-3606020	PFSK-1	brain:	n/a
15	chr11:3602845-3602895	GM12878	blood:	n/a
16	chr11:3602845-3602895	HMEC	breast:	n/a
17	chr11:3602845-3602895	HCM	heart:	n/a
18	chr11:3602845-3602895	HPAEpiC	pulmonary alveolar:	n/a
19	chr11:3602845-3602895	GM12892	blood:	n/a
20	chr11:3602845-3602895	GM19239	blood:	n/a
21	chr11:3605970-3606020	SK-N-SH_RA	brain:	n/a
22	chr11:3605970-3606020	SK-N-SH	brain:	n/a
23	chr11:3605970-3606020	T-47D	breast:	n/a
24	chr11:3602845-3602895	Jurkat	blood:	n/a
25	chr11:3602845-3602895	GM12891	blood:	n/a
26	chr11:3602845-3602895	IMR90	lung:	fetal
27	chr11:3605970-3606020	RPTEC	kidney:	n/a
28	chr11:3605970-3606020	HepG2	liver:	n/a
29	chr11:3605970-3606020	GM06990	blood:	n/a
30	chr11:3605970-3606020	K562	blood:	n/a
31	chr11:3602845-3602895	BE2_C	brain:	n/a
32	chr11:3602845-3602895	HEEpiC	esophagus:	n/a
33	chr11:3605970-3606020	PANC-1	pancreas:	n/a
34	chr11:3602845-3602895	HIPEpiC	eye:	n/a
35	chr11:3602845-3602895	NHDF-neo	bronchial:	n/a
36	chr11:3602845-3602895	HRE	kidney:	n/a
37	chr11:3605970-3606020	MCF-7	breast:	n/a
38	chr11:3605970-3606020	SK-N-MC	brain:	n/a
39	chr11:3605970-3606020	Caco-2	colon:	n/a
40	chr11:3605970-3606020	HAEpiC	amniotic membrane:	n/a
41	chr11:3602845-3602895	HUVEC	blood vessel:	n/a
42	chr11:3605970-3606020	MCF10A-Er-Src	breast:	n/a
43	chr11:3602845-3602895	LNCaP	prostate:	n/a
44	chr11:3605970-3606020	GM12891	blood:	n/a
45	chr11:3602845-3602895	HRPEpiC	eye:	n/a
46	chr11:3605970-3606020	CMK	blood:	n/a
47	chr11:3602845-3602895	U87	brain:	n/a
48	chr11:3602845-3602895	NH-A	brain:	n/a
49	chr11:3602845-3602895	PANC-1	pancreas:	n/a
50	chr11:3605970-3606020	IMR90	lung:	fetal

No data

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ART5-1	chr11:3602780-3602817	NONHSAT017602

No data

Variant related genes	Relation type
ENSG00000255367	TF binding region
ENSG00000255367	CpG island

Extended variants
information (count: 278 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:278 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs2412263	chr11:3602704-3602705	Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs2412264	chr11:3602730-3602731	Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs576968842	chr11:3602733-3602734	Bivalent Enhancer Enhancers Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs540862485	chr11:3602803-3602804	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
5	rs11820658	chr11:3602822-3602823	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs3986472	chr11:3602827-3602828	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs11827102	chr11:3602831-3602832	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs548927218	chr11:3602844-3602845	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs2412265	chr11:3602861-3602862	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs2412266	chr11:3602874-3602875	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs529104755	chr11:3602876-3602877	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs530483324	chr11:3602891-3602892	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
13	rs546529581	chr11:3602898-3602899	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs564577390	chr11:3602928-3602929	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs528732151	chr11:3602966-3602967	Bivalent Enhancer Weak transcription Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs2412268	chr11:3603029-3603030	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs2412269	chr11:3603041-3603042	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
18	rs2898930	chr11:3603043-3603044	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs2412270	chr11:3603051-3603052	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs374429556	chr11:3603056-3603057	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs3959500	chr11:3603068-3603069	Weak transcription Bivalent Enhancer Enhancers Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs2412271	chr11:3603111-3603112	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs2412272	chr11:3603121-3603122	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs529328131	chr11:3603140-3603141	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs550636505	chr11:3603141-3603142	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs372906096	chr11:3603199-3603200	Weak transcription Bivalent Enhancer Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs568918527	chr11:3603208-3603209	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs539399707	chr11:3603221-3603222	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs11028251	chr11:3603224-3603225	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs57949482	chr11:3603265-3603266	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs192986392	chr11:3603300-3603301	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs570925710	chr11:3603303-3603304	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs183908281	chr11:3603307-3603308	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs574656744	chr11:3603342-3603343	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs549184647	chr11:3603356-3603357	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs541962366	chr11:3603364-3603365	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs138333454	chr11:3603388-3603389	Weak transcription Bivalent Enhancer Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs142831689	chr11:3603457-3603458	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs187496405	chr11:3603473-3603474	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs192122111	chr11:3603476-3603477	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs184171777	chr11:3603478-3603479	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs9737048	chr11:3603487-3603488	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs369771049	chr11:3603501-3603502	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs561969529	chr11:3603510-3603511	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs529415058	chr11:3603511-3603512	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs376677470	chr11:3603529-3603530	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs550661148	chr11:3603553-3603554	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs569004547	chr11:3603556-3603557	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs149415915	chr11:3603598-3603599	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs533192979	chr11:3603601-3603602	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	19432969	CNVD
Alzheimer''s disease	17576883	CNVD
Long-qt syndrome	17576883	CNVD
Emphysema	19352772	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Chordoma	18071362	CNVD
Breast cancer	16608533	CNVD
Cancer	21183584	CNVD
Gastric adenocarcinoma	19115996	CNVD
Hepatocellular carcinoma	16750200	CNVD
Burkitt''s lymphoma	19759907	CNVD
Breast cancer	17603634	CNVD
Medulloblastoma	21979893	CNVD
Thyroid cancer	19087340	CNVD
Melanoma	18172304	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Wilms tumour	21544195	CNVD
Parathyroid adenoma	22454399	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Gastric cancer	17908304	CNVD
Barrett''s syndrome	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
Myelofibrosis	22110671	CNVD
Glioma	17123091	CNVD
Lung cancer	16773561	CNVD
Neuroblastoma	21124317	CNVD
Lung adenocarcinoma	17086460	CNVD
Lung cancer	17086460	CNVD
Schizophrenia	21399695	CNVD
Gastric cancer	16891809	CNVD
Cancer	17160897	CNVD
Multiple myeloma	16616336	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:111 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:3600800-3602800	Active TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
2	chr11:3601400-3602800	Active TSS	Rectal Mucosa Donor 29	rectum
3	chr11:3601400-3603200	Active TSS	Fetal Intestine Large	intestine
4	chr11:3601600-3602800	Active TSS	H9 Cell Line	embryonic stem cell
5	chr11:3602200-3602800	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
6	chr11:3602200-3602800	Enhancers	Lung	lung
7	chr11:3602200-3602800	Bivalent Enhancer	Skeletal Muscle Female	skeletal muscle
8	chr11:3602400-3602800	Enhancers	ES-WA7 Cell Line	embryonic stem cell
9	chr11:3602400-3602800	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
10	chr11:3602400-3602800	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr11:3602400-3602800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr11:3602400-3602800	Enhancers	Primary B cells from peripheral blood	blood
13	chr11:3602400-3602800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
14	chr11:3602400-3602800	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
15	chr11:3602400-3602800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
16	chr11:3602400-3602800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
17	chr11:3602400-3602800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
18	chr11:3602400-3602800	Enhancers	Colon Smooth Muscle	Colon
19	chr11:3602400-3602800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
20	chr11:3602400-3602800	Bivalent Enhancer	Placenta	Placenta
21	chr11:3602400-3602800	Bivalent Enhancer	Fetal Thymus	thymus
22	chr11:3602400-3602800	Enhancers	Pancreas	Pancrea
23	chr11:3602400-3602800	Enhancers	Psoas Muscle	Psoas
24	chr11:3602400-3602800	Enhancers	Sigmoid Colon	Sigmoid Colon
25	chr11:3602400-3602800	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
26	chr11:3602400-3602800	Bivalent Enhancer	Stomach Smooth Muscle	stomach
27	chr11:3602400-3602800	Enhancers	A549	lung
28	chr11:3602400-3602800	Enhancers	HepG2	liver
29	chr11:3602400-3603000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
30	chr11:3602400-3603000	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
31	chr11:3602400-3603400	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
32	chr11:3602400-3603400	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
33	chr11:3602600-3602800	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
34	chr11:3602600-3602800	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
35	chr11:3602600-3602800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
36	chr11:3602600-3602800	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr11:3602600-3602800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
38	chr11:3602600-3602800	Enhancers	Primary T helper naive cells fromperipheralblood	blood
39	chr11:3602600-3602800	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
40	chr11:3602600-3602800	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
41	chr11:3602600-3602800	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
42	chr11:3602600-3602800	Flanking Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
43	chr11:3602600-3602800	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
44	chr11:3602600-3602800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr11:3602600-3602800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
46	chr11:3602600-3602800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
47	chr11:3602600-3602800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr11:3602600-3602800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
49	chr11:3602600-3602800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
50	chr11:3602600-3602800	Enhancers	Adipose Nuclei	Adipose

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links